ENDRA Life Sciences to Participate in Two March Investor Conferences

Rhea-AI Summary

ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced participation in two investor conferences in March. The company will attend the 34th Annual ROTH Conference from March 13-15, 2022, where management will be available for one-on-one meetings on March 14 and a pre-recorded presentation will be posted online. Additionally, ENDRA will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 15 at 2:40 p.m. ET and offer virtual one-on-one meetings. ENDRA is known for its TAEUS® technology for liver health assessment.

ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS^®), announces that management will participate in two investor conferences during March:

• 34^th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton Laguna Niguel. Management will be available for one-on-one meetings on Monday, March 14, 2022. In addition, a pre-recorded company presentation will be available in the Investors section of ENDRA’s website here.

• Oppenheimer’s 32^nd Annual Healthcare Conference, March 15-16, 2022. Management will deliver a company presentation on Tuesday, March 15^th at 2:40 p.m. ET and will be available for one-on-one virtual meetings.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS^®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50^th the cost and at the point of patient care. TAEUS^® is designed to work in concert with 400,000 cart-based ultrasound systems in use globally today. TAEUS^® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS^®, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220303005114/en/

Company Contact:

Irina Pestrikova

Senior Director, Finance

investors@endrainc.com

www.endrainc.com

Investor Relations Contact:

Yvonne Briggs

LHA Investor Relations

(310) 691-7100

YBriggs@lhai.com

Source: ENDRA Life Sciences Inc.

FAQ

What are the details of ENDRA Life Sciences' participation in the 34th Annual ROTH Conference?

ENDRA Life Sciences Inc. will participate in the 34th Annual ROTH Conference from March 13-15, 2022, with management available for one-on-one meetings on March 14.

When will ENDRA Life Sciences present at Oppenheimer’s 32nd Annual Healthcare Conference?

ENDRA Life Sciences will present at Oppenheimer’s 32nd Annual Healthcare Conference on March 15, 2022, at 2:40 p.m. ET.

What technology does ENDRA Life Sciences focus on?

ENDRA Life Sciences is focused on Thermo Acoustic Enhanced UltraSound (TAEUS®), which aims to visualize tissue and assess liver conditions.

What is the significance of TAEUS® for liver health?

TAEUS® is designed to measure fat in the liver, helping to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH, chronic liver conditions.

Where can I find more information about ENDRA Life Sciences?

More information about ENDRA Life Sciences can be found on their website at www.endrainc.com.